AMG 330 Appears Safe, Tolerable in Relapsed/Refractory Acute Myeloid Leukemia
The most common, expected, and reversible treatment-emergent adverse event associated with the agent was cytokine release syndrome.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Kristie L. Kahl Source Type: news